Adial Pharmaceuticals, Inc. (AZR) stock
AZRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$3.67−0.15 (-3.81%)
Close on Nov 17, 2026Market cap $9.62MP/E –Yield –
Adial Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Adial Pharmaceuticals's enterprise value was -$19.50M on Nov 11, 2026, against $2.87M a year earlier. Over the last 5 years it ranged from -$19.50M to $48.03M, with a median of $1.09M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$19.50M | -3157.0% |
| 2025 | Dec 31, 2025 | $637.71K | -49.6% |
| 2024 | Dec 31, 2024 | $1.27M | -35.1% |
| 2023 | Dec 29, 2023 | $1.95M | +9232.0% |
| 2022 | Dec 30, 2022 | $20.89K | -100.0% |
| 2021 | Dec 31, 2021 | $48.03M | +185.8% |
| 2020 | Dec 31, 2020 | $16.81M | +3.2% |
| 2019 | Dec 31, 2019 | $16.28M | -43.4% |
| 2018 | Dec 31, 2018 | $28.75M | – |
See a number that looks wrong?